Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023-08 · 43 (8) · 816-832
DOI: 10.1002/phar.2806 ↗At a glance
Übersichtsarbeit in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, published online on 2023-05-14. Written by Nikki N Tran and 4 co-authors. Institution: Department of Pharmacy, The Ohio State University Wexner Medical Center - The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, US…. Major MEDLINE topics: Staphylococcal Infections, Community-Acquired Infections, Methicillin-Resistant Staphylococcus aureus. Cited 74 times so far (Crossref); 177 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections and contributes to significant increase in morbidity and mortality especially when associated with medical devices and in biofilm form. Biofilm structure provides a pathway for the enrichment of resistant and persistent phenotypes of S. aureus leading to relapse and recurrence of infection. Minimal diffusion of antibiotics inside biofilm structure leads to heterogeneity and distinct physiological activity. Additionally, horizontal gene transfer between cells in proximity adds to the challenges associated with eradication of biofilms. This narrative review focuses on biofilm‐associated infections caused by S. aureus , the impact of environmental conditions on biofilm formation, interactions inside biofilm communities, and the clinical challenges that they present. Conclusively, potential solutions, novel treatment strategies, combination therapies, and reported alternatives are discussed.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, The Ohio State University Wexner Medical Center - The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA.
- Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, USA.
- Department of Pharmacy Services, Medical University of South Carolina Shawn Jenkins Children's Hospital, Charleston, South Carolina, USA.
- Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- P3 Research Laboratory, Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
ORCID profiles: Sarah C J Jorgensen, Razieh Kebriaei
Cite
APA
Tran, N. N., Morrisette, T., Jorgensen, S. C. J., Orench-Benvenutti, J. M., & Kebriaei, R. (2023). Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43(8), 816-832. https://doi.org/10.1002/phar.2806
Vancouver
Tran NN, Morrisette T, Jorgensen SCJ, Orench-Benvenutti JM, Kebriaei R. Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023;43(8):816-832. doi:10.1002/phar.2806
BibTeX
@article{Tran2023,
author = {Tran, Nikki N and Morrisette, Taylor and Jorgensen, Sarah C J and Orench-Benvenutti, José M and Kebriaei, Razieh},
title = {Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2023},
volume = {43},
number = {8},
pages = {816--832},
doi = {10.1002/phar.2806}
}
EUVIMED